BioSpace News Archive

Press Releases

SystImmune and Bristol Myers Squibb Highlight Positive Phase III Interim Topline Results for izalontamab brengitecan (Iza-bren) in Previously Treated Unresectable Locally Advanced or Metastatic Triple-Negative Breast Cancer

February 26, 2026
·
7 min read
Press Releases

Lilly’s oral GLP-1, orforglipron, delivered superior blood sugar control and weight loss compared to oral semaglutide in head-to-head type 2 diabetes trial published in The Lancet

February 26, 2026
·
10 min read
Press Releases

Amphista Therapeutics presents new data demonstrating how its advanced Eclipsys® platform is delivering Targeted Glue™ degraders using novel E3 ligases into the clinic

February 26, 2026
·
4 min read
Press Releases

Conavi Medical Reports Fiscal First Quarter 2026 Results and Operational Highlights

February 26, 2026
·
7 min read
Press Releases

Boehringer Ingelheim licenses novel oral therapeutics program for immune diseases from Sitryx Therapeutics

February 26, 2026
·
3 min read
Press Releases

Compass Pathways Announces Exercise of $200 Million in Outstanding Warrants

February 26, 2026
·
4 min read
Press Releases

UK-China talks on Thermobalancing therapy for kidney stones, enlarged/inflamed prostate, back pain and joints problems

February 26, 2026
·
2 min read
Press Releases

Aveanna Announces Fourth Quarter and Full Year 2025 Earnings Release Date and Conference Call

February 26, 2026
·
1 min read
Press Releases

BioCryst Reports Full Year 2025 Financial Results and Provides Business Update

February 26, 2026
·
18 min read
Press Releases

Anika Reports Fourth Quarter and Full Year 2025 Financial Results

February 26, 2026
·
17 min read